Dr Stefanie Chan
Dr Stefanie Chan is currently a Postdoctoral Researcher at the Centre for Nutraceuticals, specialising in supplement formulation development. Dr Chan possesses prior industrial experience in formulation development, during which she led cross-functional teams to develop and commercialise nutraceutical products that are now successfully launched in the UK market. Through comprehensive market analysis, she strategically guided product development to align with industry trends and consumer demands. Moreover, Dr Chan also conducts clinical trials at the Centre for Nutraceuticals to evaluate supplements aimed at improving cognitive function and exercise performance.
Dr Chan holds a PhD in Regulatory Science, completed through a 4-year funded academic-industrial collaboration with IQVIA and the University of Hertfordshire (UH). Her doctoral research focused on the investigation of cardiotoxic effects of non-small cell lung cancer (NSCLC) treatments, conducted under the guidance of Professor Sam Salek and Dr Sherael Webley at UH, and Professor Deborah Layton from IQVIA. She was also a recipient of the Jenny Greenhorn Memorial Scholarship.
Dr Chan received her BSc (Hons) in Pharmaceutical Science from Kingston University London and her MSc in Pharmaceutics from University College London (UCL). Following her Master’s degree, she joined UCL School of Pharmacy as a research scientist, where she contributed to diverse projects, including the design and development of innovative nanoformulations, dry powder formulations and prenatal oral formulations. Additionally, she conducted a PharmAlliance project in collaboration with Monash University (Australia) and the University of North Carolina at Chapel Hill (USA), which involved creating and validating a virtual HPLC simulator for enhancing educational methodologies in pharmaceutical sciences.
Dr Chan’s research interests encompass nanomedicine, formulation development, pharmacovigilance, pharmacoepidemiology, and real-world data analysis. She has collaborated with interdisciplinary teams of professionals, contributing to publications in peer-reviewed journals and presentations at international conferences.
Dr Chan’s research contributions have been recognised through awards, including the ‘Best Poster Award’ at the JPAG Pharmaceutical Analysis Research Awards and Careers Symposium 2021, sponsored by the Royal Society of Chemistry and Royal Pharmaceutical Society, for her presentation on 'Dry Powder Formulation of Azithromycin for COVID-19'.